VIVET ATTENDING CHARDAN’S 4th ANNUAL GENETIC MEDICINES CONFERENCE
VIVET ATTENDING CHARDAN’S 4th ANNUAL GENETIC MEDICINES CONFERENCE
VIVET IS PARTICIPATING TO THE HEALTHTECH INNOVATION DAYS 2020 (HTID) IN PARIS
VIVET ATTENDING THE HEALTHTECH INNOVATION DAYS (HTID) IN PARIS
VIVET IS PARTICIPATING TO THE PAEDIATRIC CHOLESTASIS WORKSHOP – PART ONE 2020
Bernard Benichou Vivet Therapeutics’ CMO will be participating to a panel and Jean-Philippe Combal, CEO and Sonia Valero, Head of Clinical Operations…
Vivet Therapeutics Announces 2 Abstracts Presentation At 2020 ASGCT Annual Meeting
Vivet Therapeutics, a privately held gene therapy biotech company
Vivet presenting during Advanced Therapies 2020 in London
Vivet Therapeutics’ CEO, Jean-Philippe Combal
Vivet attending Jefferies 2019 London Healthcare Conference
Jean-Philippe Combal, Vivet Therapeutics’ CEO, and Thomas Daniel, BD Director, will be hosting 1×1 meetings during
Vivet Presenting at 2019 World Orphan Drug Congress Europe in Barcelona
Vivet Therapeutics CEO, Jean-Philippe Combal
VIVET THERAPEUTICS PRESENTING DURING AASLD – THE LIVER MEETING 2019 IN BOSTON
Dr. Gloria González-Aseguinolaza, Vivet Therapeutics CSO
Vivet Therapeutics Presenting New Results During 2019 ESGCT Annual Congress in Barcelona
Dr. Gloria González-Aseguinolaza, Vivet Therapeutics CSO & Head of the Gene Therapy
VIVET PRESENTING DURING 2019 GENE THERAPY FOR RARE DISORDERS EUROPE CONFERENCE IN LONDON
Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation (“Manufacturing of a New Gene Therapy Product: Long…